Aeglea BioTherapeutics (NASDAQ:AGLE) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a report issued on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Other research analysts have also issued reports about the company. Lifesci Capital lowered Aeglea BioTherapeutics from an outperform rating to a market perform rating in a […]

Related Keywords

Aeglea Biotherapeutics ,Aeglea Biotherapeutics Inc ,Wells Fargo Company ,Carlyle Group Inc ,Sphera Funds Management ,Aeglea Biotherapeutics Company Profile ,Get Rating ,Point Capital Management ,Sigma Investments ,Funds Management ,Two Sigma Advisers ,Sigma Advisers ,Nasdaq Agle ,Beagle ,Medical ,Initiated Coverage ,Stocknews Com ,